共 4 条
[1]
Effects of SREBF-1a and SCAP polymorphisms on plasma levels of lipids, severity, progression and regression of coronary atherosclerosis and response to therapy with fluvastatin
[J].
JOURNAL OF MOLECULAR MEDICINE-JMM,
2002, 80 (11)
:737-744
[3]
[4]

